A Multicenter Randomized Trial Assessing ZENFlow Carrier-Free Drug-Coated Balloon for the Treatment of Femoropopliteal Artery Lesions

A Multicenter Randomized Trial Assessing ZENFlow Carrier-Free Drug-Coated Balloon for the Treatment of Femoropopliteal Artery Lesions

Backgrounds and ObjectivesDrug-coated balloons (DCBs) have shown promising benefits in improving the outcomes for patients with peripheral artery disease. Several randomized clinical trials have reported that paclitaxel-coated balloon significantly reduce the rates of restenosis and the need for rei...

Full description

Bibliographic Details
Main Authors: Leng Ni, Wei Ye, Lan Zhang, Xing Jin, Chang Shu, Jin-song Jiang, Mu Yang, Dan-ming Wu, Ming Li, Guan-feng Yu, Jun Yang, Jian-hua Huang, Xiao-bai Wang, Xiao-qiang Li, Wei-liang Jiang, Zhi-qun Wu, Chang-wei Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
drug-coated balloon
paclitaxel
percutaneous transluminal angioplasty
restenosis
peripheral artery disease
femoropopliteal artery occlusive disease
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.821672/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.821672/full

Similar Items